Inventor
BONO FRANCOISE
FR19 patents
⚠️ This page may combine multiple inventors who share the name “BONO FRANCOISE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI AVENTIS
7 patentsUS7468368B2Dec 23, 2008
Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
SANOFI AVENTIS10 citations82
US7442708B2Oct 28, 2008
1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
SANOFI AVENTIS8 citations72
US7294628B2Nov 13, 2007
Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
SANOFI AVENTIS7 citations72
US7553845B2Jun 30, 2009
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives
SANOFI AVENTIS4 citations60
US8008321B2Aug 30, 2011
Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
SANOFI AVENTIS0 citations50
US7803811B2Sep 28, 2010
1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for preparing them and pharmaceutical compositions containing them
SANOFI AVENTIS0 citations50
US8034828B2Oct 11, 2011
Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis
SANOFI AVENTIS0 citations37
BARONI MARCO
5 patentsUS8580790B2Nov 12, 2013
(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors
BARONI MARCO7 citations81
US8518947B2Aug 27, 2013
(Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
BARONI MARCO3 citations60
US8247404B2Aug 21, 2012
Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
BARONI MARCO2 citations60
US8193190B2Jun 5, 2012
Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
BARONI MARCO5 citations60
US8519143B2Aug 27, 2013
Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
BARONI MARCO1 citations50
ALAM ANTOINE
3 patentsUS8470847B2Jun 25, 2013
Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
ALAM ANTOINE5 citations67
US8263614B2Sep 11, 2012
Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
ALAM ANTOINE3 citations59
US8586602B2Nov 19, 2013
Derivatives of 7 alkynyl-1,8 naphthyridones, preparation method thereof and use of same in therapeutics
ALAM ANTOINE0 citations43
SANOFI SA
2 patentsUS8906924B2Dec 9, 2014
(heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
SANOFI SA2 citations60
US8957211B2Feb 17, 2015
(Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors
SANOFI SA1 citations49